The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 167.50
Bid: 165.00
Ask: 170.00
Change: 2.50 (1.52%)
Spread: 5.00 (3.03%)
Open: 165.00
High: 167.50
Low: 165.00
Prev. Close: 165.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Syndicate Mid Point Forecasts

4 Apr 2023 07:00

RNS Number : 2139V
Helios Underwriting Plc
04 April 2023
 

4th April 2023

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Quarterly Syndicate Mid Point Forecasts

 

Helios, the unique investment vehicle which acquires and consolidates private underwriting capacity at Lloyd's, announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2020 and 2021 years of account based on 4th quarter 2022 estimates.

 

Martin Reith, Chief Executive, commented:

 

"Helios' unique proposition, as the only listed consolidator of private capital at Lloyd's, is well positioned to benefit from the Lloyd's market's recently announced mid point forecasts. Helios has built and curated an outstanding portfolio of the better performing syndicates and, as a consequence of underwriting discipline and judicious capital deployment, we are delighted to see improved underwriting profitability in the Lloyd's market. We expect Helios' portfolio to continue to outperform the market as we have since 2013 for closed years of accounts.

 

Recognising stronger market conditions, we increased our retained capacity to £238m for the 2023 year of account, an increase of 34%. We remain confident that we shall deliver improved results and superior return on equity underpinned by our favourable Economic Capital Assessment (ECA), and look forward to creating further shareholder value as the benefits of the larger retained capacity flows to the income statement."

 

Year of Account

 

 

2020

2021

2022

2023

 

 

£m

£m

£m

£m

 

Capacity - Position as at 30th September 2022

 

Retained

66.5

93.5

171.9

 

Reinsured

49.1

51.5

60.8

 

115.6

145.0

232.7

 

Capacity Acquired since 30th September 2022

 

 

Retained

5.6

5.8

5.7

 

Reinsured

0.0

0.0

0.0

 

5.6

5.8

5.7

 

Total capacity as at 31st March 2023

 

Retained

72.0

99.3

177.6

238.4

 

Reinsured

49.1

51.5

60.8

58.3

 

121.2

150.8

238.4

296.7

 

Mid-point forecast at 30th September 2022

1.94%

2.29%

 

Final result / Current mid-point forecast

3.11%

2.37%

 

Lloyd's Market Average

0.91%

4.20%

 

Helios out performance

2.20%

(1.83)%

 

 

Commentary

 

The 2020 result showed an improvement over the midpoint forecasts as at 30th September 2022. The overall result was impacted by the negative investment returns recognised during the year and the impact from the COVID-19 pandemic.

 

The development of the mid point estimate for 2021 has been held back by losses from Ukraine that were recognised in 2022. The improved returns from the investment portfolio should benefit this year before it closes at the end of this year.

 

The 2022 underwriting year has been impacted by the loss from Hurricane Ian that will create a drag on the earnings recognised in 2022.

 

The outperformance of 2.2% of the portfolio against the average for the Lloyd's market for 2020 continues the trend of closed year of account outperformance achieved since 2013.

 

Notes

1) The table above shows the capacity as at 31st March 2023, splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers. 

2) The mid-point forecasts for 2020 and 2021 years of account as of 4th quarter 2022 have been aggregated at syndicate level from estimates supplied by Managing Agents.

3) The impact on Helios will be as follows:

a. The change in the mid point estimates on the retained capacity over the year will be recognised in the Helios income statement in the year to 31st December 2022.

b. The overall change in the result will be recognised by Helios in cash at the close of the year of account.

 

For further information, please contact:

Helios Underwriting plc

 

Helios Underwriting plc

Martin Reith - Chief Executive +44(0)7720 292 505

Nigel Hanbury - Executive Deputy Chairman +44(0)7787 530 404

Arthur Manners - Chief Financial Officer +44(0)7754 965 917

 

Shore Capital

Robert Finlay +44(0)20 77408 4080

David Coaten

Henry Willcocks

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £297m of capacity for the 2023 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUGACUPWGAW
Date   Source Headline
2nd Oct 20237:00 amRNSTotal Voting Rights
28th Sep 20237:00 amRNSHalf Year Results
11th Sep 202311:46 amRNSTransaction in Own Shares
8th Sep 202310:23 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20233:27 pmRNSTransaction in Own Shares
4th Sep 20233:36 pmRNSTransaction in Own Shares
1st Sep 202311:06 amRNSTransaction in Own Shares
1st Sep 20237:00 amRNSTotal Voting Rights
31st Aug 202311:05 amRNSTransaction in Own Shares
30th Aug 20234:05 pmRNSTransaction in Own Shares
30th Aug 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
29th Aug 202312:30 pmRNSTransaction in Own Shares
25th Aug 20232:12 pmRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in own shares
23rd Aug 202311:44 amRNSShare Repurchase Programme
21st Aug 20234:23 pmRNSNotification of Major Holdings
21st Aug 202311:40 amRNSDirector's Shareholding
18th Aug 20238:22 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20234:30 pmRNSShare Repurchase Programme
2nd Aug 20237:00 amRNSTotal Voting Rights
25th Jul 20237:00 amRNSAcquisition
14th Jul 20237:00 amRNSDirector Dealing
14th Jul 20237:00 amRNSAcquisition of Limited Liability Vehicle
13th Jul 20237:00 amRNSIssue of Equity
4th Jul 20237:00 amRNSResults of Scrip Dividend Election
29th Jun 20233:46 pmRNSDirectorship Change
29th Jun 202311:27 amRNSResults of Annual General Meeting
29th Jun 20237:00 amRNSNotification of Major Holdings
16th Jun 20237:00 amRNSScrip Dividend Reference Price
7th Jun 20233:53 pmRNSDirector’s Shareholding
5th Jun 20233:39 pmRNSFinal Dividend Timetable
5th Jun 20237:00 amRNSDirector’s/PCA Shareholdings
1st Jun 20237:00 amRNSGrant of LTIP Award
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
31st May 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
26th May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSChange of Adviser
11th May 20237:00 amRNSDirectors' Disclosure
11th Apr 20237:00 amRNSDirector's/PCAs' Shareholding
5th Apr 20237:00 amRNSGrant of LTIP Award and Director Dealing
5th Apr 20237:00 amRNSDirector/PCA Shareholdings
4th Apr 20237:00 amRNSDirectorate Change
4th Apr 20237:00 amRNSQuarterly Syndicate Mid Point Forecasts
10th Jan 20237:00 amRNS2023 Helios Retained Capacity Update
29th Dec 20223:38 pmRNSAcquisitions of LLVs, Issue of Equity and TVR
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 202212:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.